Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Sales/Fixed Asset

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Sales/Fixed Asset History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Sales/Fixed Asset(x) 2.772.742.942.971.44

What is the latest Sales/Fixed Asset ratio of GLENMARK PHARMACEUTICALS ?

The latest Sales/Fixed Asset ratio of GLENMARK PHARMACEUTICALS is 2.77 based on Mar2024 Consolidated results.
Year Sales/Fixed Asset
Mar20242.77
Mar20232.74
Mar20222.94
Mar20212.97
Mar20201.44

How is Sales/Fixed Asset of GLENMARK PHARMACEUTICALS Trending?

Years Sales/Fixed Asset % Change
Mar2024 2.77
1.09
Mar2023 2.74
-6.80
Mar2022 2.94
-1.01
Mar2021 2.97
106.25
Mar2020 1.44 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Sales/Fixed Asset ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹41,680.9 Cr -7.3% -4.8% 72.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,527.0 Cr -3.8% -3% 34.3% Stock Analytics
DIVIS LABORATORIES ₹156,037.0 Cr 0.9% 0.4% 53.5% Stock Analytics
CIPLA ₹116,854.0 Cr -2.8% -0.1% 9.3% Stock Analytics
DR REDDYS LABORATORIES ₹111,746.0 Cr -2.4% 5.5% 17.5% Stock Analytics
ZYDUS LIFESCIENCES ₹99,093.9 Cr -2.4% -0.3% 42.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-7.3%

-4.8%

72.3%

SENSEX

-1.8%

-6.6%

7.1%


You may also like the below Video Courses